Related Experiment Video
Updated: May 28, 2025

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring
Published on: May 21, 2017
Enhanced hemostatic efficacy of cryogel with copper ion-loaded mesoporous bioactive glasses for acute and persistent
Qixiu Hou1,2,3, Xu He4, Mengting Guo1,2,3
1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, 215500, China.
Abstract:
Uncontrolled acute and persistent bleeding, as well as with infection, is a great challenge because of the high mortality during treating the patients with injuries, complex surgery or bone marrow failure. Here, we develop an external form of natural components which is based on phosphorylated methacrylated gelatin (GelMA, G) cryogel (GP) loaded with tannic acid (TA)-mixed copper ion (Cu2+) mesoporous bioactive glasses (MBG), named after GP@MBG-Cu-TA cryogel, to address the goals of reduce persistent bleeding and enhance antibacterial activity. Structurally, GP@MBG-Cu-TA cryogel is based on GP, MBG loaded with TA and Cu2+ adheres to GP via hydrogen bonding. In vitro, GP@MBG-Cu-TA cryogel displays a good biocompatibility, hemostatic and antimicrobial capability. In vivo studies, GP@MBG-Cu-TA cryogel can enhance the hemostatic effect in the liver injury in SD rats for the acute bleeding, as well as in the aplastic anemia and hemophilia A mice with tail amputation for the persistent bleeding. In addition, GP@MBG-Cu-TA cryogel accelerates the skin wound repair in the mice with the bacterial contamination at the injury site. In sum, GP@MBG-Cu-TA cryogel is not only endowed with dual function of hemostatic and antimicrobial capability, but also can stop bleeding of the objects with either normal or abnormal coagulation function. Thus, GP@MBG-Cu-TA cryogel provides a promising candidate dressing for managing bleeding and bacterial complications in clinic.
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Clot Retraction and Fibrinolysis

